Menorrhagia—a pragmatic approach to the understanding of causes and the need for investigations
article
OA: closed
CC0
⤵ 12 in-corpus citations
Abstract
Menorrhagia is a symptom denoting excessively heavy menstrual bleeding. It is a complaint that is difficult to verify objectively in many cases, even with a detailed case history. Issues of perception and tolerance of symptoms are important in whether a patient presents to a doctor, and this varies considerably from one society to another. Research studies indicate that the upper limit of normal blood loss is between 60 and 80 ml/month. Above this level women tend to become progressively iron deficient. Hence, any development which may help the precision of this assessment is valuable, and several of these will be discussed. Causes of menorrhagia can be divided into three groups: (1) pelvic diseases, such as myomata and adenomyosis; (2) systemic disorders, such as coagulopathies and hypothyroidism; and (3) dysfunctional uterine bleeding--a diagnosis of exclusion. Investigations are mainly aimed at improving the precision of the underlying diagnosis, defining the severity of the condition and excluding anaemia. Hence, the most important investigations are a full blood count, a diagnostic hysteroscopy and endometrial sampling. In clinical practice, other specific investigations need only be carried out if there are unusual features in the history or examination, or if previous treatments have failed. In a research situation there have been numerous studies aimed at elucidation of the mechanisms of heavy bleeding and some of these will be reviewed.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (19)
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- Endometriosis: Associations with Menorrhagia, Infertility and Oral Contraceptives via openalex
- W1538894163 via openalex
- W1690780888 via openalex
- W1967882448 via openalex
- W1978050262 via openalex
- W2012165536 via openalex
- W2024180604 via openalex
- W2040918473 via openalex
- W2042374015 via openalex
- W2045714297 via openalex
- W2056895439 via openalex
- W2075790322 via openalex
- W2077702210 via openalex
- W4247840597 via openalex
- W4299952610 via openalex
- W3470488 via openalex
- W6607915620 via openalex
- W196080874 via openalex
Cited by (12)
- Peri- and Postmenopausal Uterine Bleeding Transvaginal Ultrasound with Hysterosonography and Diagnostic Correlation with Hysteroscopy 2011
- Adenomiose em pacientes com endometriose profunda: aspectos clínicos, histológicos e radiológicos 2010
- The uterine junctional zone 2006
- MENSTRUAL DISORDERS 1999
- Abnormal uterine bleeding in the reproductive years. Part I—Pathogenesis and clinical investigation 1999
- General practitioners' perceptions of the illness behaviour and health needs of South Asian women with Menorrhagia 1998
- Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi‐centre study 1998
- Medium-term follow-up of women with menorrhagia treated by rollerball endometrial ablation 1996
- Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: a multicentre, randomised controlled trial 1996
- Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia 1996
- Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics 1995
- Uterine junctional zone: function and disease 1995
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:11:24.284338+00:00
License: CC0
· commercial use OK